NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product. Eligibility: Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed. CFDA: 93.143, 93.286, 93.394, 93.865, 93.350, 93.068, 93.853, 93.361, 93.307, 93.103, 93.395, 93.273, 93.846, 93.855, 93.142, 93.213, 93.073, 93.233, 93.866, 93.351, 93.837, 93.847, 93.840, 93.313, 93.242, 93.879, 93.393, 93.859, 93.172, 93.173, 93.839, 93.083, 93.136, 93.070, 93.084, 93.326, 93.838, 93.867, 93.279, 93.121, 93.113